Clinical Laboratory Testing Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel), By End-use, And Segment Forecasts, 2013 - 2024

Published: Dec, 2016 | Pages: 140 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The global clinical laboratory testing market is expected to reach USD 198.5 billion by 2024, based on a new study by Grand View Research, Inc. Introduction of innovative solutions on the grounds of maximum efficiency and minimum error is expected to serve this market as a high impact-rendering driver.

Integrated workflow management systems, database management tools and patient test records are becoming increasingly important in the healthcare industry with companies processing as many as 100 to 150 billion samples per year.

Development and implementation of various informatics and data management solutions for performing seamless operations is expected to drive the growth of this market. Availability of technologically advanced products such as chemistry analyzers with high yield, low maintenance and, ease of usage has heightened the demand for early disease detection.

Increasing prevalence of chronic diseases and the consequent need to curb healthcare expenditure is also expected to drive market growth by increasing the demand for early and regular disease diagnosis. Moreover, presence of favorable reimbursement policies and availability of CLIA waived test is anticipated to increase base of target population.

Further Key Findings from the Study Suggest:

•	The basic metabolic panel segment dominated the clinical laboratory test market in 2015 mainly due to high acceptance rate of this panel of tests

•	Liver panel is estimated to witness highest growth for liver cirrhosis testing owing to high rate of alcohol consumption

•	Increasing demand for testing of blood lipid levels in cardiovascular and diabetes patients is anticipated to attribute towards significant growth of liver panel over the forecast period.

•	Extensive support of manpower and established infrastructure are the main factors attributing to largest share of central laboratories

•	North America is the most developed clinical laboratory tests market due to factors such as high awareness levels, rising prevalence of cardiovascular disorders, and high market penetration of technologically advanced diagnostic techniques

•	Asia Pacific is anticipated to witness significant growth over 9% during the forecast period with presence of huge untapped opportunities, increasing base of target population, and positive economic growth.

•	Some of the key companies are Quest Diagnostics, Millipore Sigma, LabCorp, and Genoptix Medical Laboratory

•	Strategic initiatives implemented by key players to maintain market position include merger and acquisition of small players and development of cost effective clinical tests.

 Table of Contents


Chapter 1 Research Methodology & Scope
                     1.1 Information Procurement
                          1.1.1 Purchased database:
                          1.1.2 GVR's internal database
                     1.2 Research Methodology
                     1.3 Geographic Scope &Assumptions
                     1.4 Region-wise Market Calculation
                          1.4.1 Region-wise market: Base estimates
                          1.4.2 Global market: CAGR calculation
                     1.5 Region-based Segment Share Calculation
                     1.6 List of Secondary Sources

Chapter 2 Executive Summary
                     2.1 Market Snapshot

Chapter 3 Clinical Laboratory Testing Market Variables, Trends & Scope
                     3.1 Market Segmentation & Scope
                          3.1.1 Market driver analysis
                                3.1.1.1 Rising geriatric population base
                                3.1.1.2 Growing prevalence of target diseases
                                3.1.1.3 Introduction of innovative solutions
                                3.1.1.4 Rising demand for early disease detection
                          3.1.2 Market restraint analysis
                                3.1.2.1 Presence of ambiguous regulatory framework
                     3.2 Penetration & Growth Prospect Mapping
                     3.3 Clinical Laboratory Test- SWOT Analysis, By Factor (political & legal, economic and technological)
                     3.4 Industry Analysis - Porter's

Chapter 4 Clinical Laboratory Testing Market: Type Estimates & Trend Analysis
                     4.1 Clinical Laboratory Testing Market: Type movement analysis
                     4.2 Complete Blood Count
                          4.2.1 Complete blood count market, 2013 - 2024 (USD Billion)
                     4.3 HGB/HCT testing
                          4.3.1 HGB/HCT testing market, 2013 - 2024 (USD Billion)
                     4.4 Basic Metabolic Panel Testing
                          4.4.1 Basic metabolic panel testing market, 2013 - 2024 (USD Billion)
                     4.5 BUN Creatinine Testing
                          4.5.1 BUN creatinine testing market, 2013 - 2024 (USD Billion)
                     4.6 Electrolytes Testing
                          4.6.1 Electrolytes testing market, 2013 - 2024 (USD Billion)
                     4.7 HbA1c Testing
                          4.7.1 HbA1c testing market, 2013 - 2024 (USD Billion)
                     4.8 Comprehensive Metabolic Panel Testing
                          4.8.1 Comprehensive metabolic panel testing market, 2013 - 2024 (USD Billion)
                     4.9 Liver Panel Testing
                          4.9.1 Liver panel testing market, 2013 - 2024 (USD Billion)
                     4.10 Renal Panel Testing
                          4.10.1 Renal panel testing market, 2013 - 2024 (USD Billion)
                     4.11 Lipid Panel Testing
                          4.11.1 Lipid panel testing market, 2013 - 2024 (USD Billion)

Chapter 5 Clinical Laboratory Testing Market: End-use Estimates & Trend Analysis
                     5.1 Clinical Laboratory Testing Market: End-use movement analysis
                     5.2 Primary Clinics
                          5.2.1 Primary clinics market, 2013 - 2024 (USD Billion)
                     5.3 Central Laboratories
                          5.3.1 Central laboratories market, 2013 - 2024 (USD Billion)

Chapter 6 Clinical Laboratory Testing Market: Regional Estimates & Trend Analysis, by Type
                     6.1 Clinical Laboratory Testing Market Share by Region, 2015 & 2024
                     6.2 North America
                          6.2.1 North America clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.2.2 U.S.
                                6.2.2.1 U.S. Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.2.3 Canada
                                6.2.3.1 Canada Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                     6.3 Europe
                          6.3.1 Europe Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.3.2 UK
                                6.3.2.1 UK Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.3.3 Germany
                                6.3.3.1 Germany Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                     6.4 Asia Pacific
                          6.4.1 Asia Pacific Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.4.2 Japan
                                6.4.2.1 Japan Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.4.3 China
                                6.4.3.1 China Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.4.4 India
                                6.4.4.1 India Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                     6.5 Latin America
                          6.5.1 Latin America Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.5.2 Brazil
                                6.5.2.1 Brazil Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.5.3 Mexico
                                6.5.3.1 Mexico Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                     6.6 MEA
                          6.6.1 MEA Clinical laboratory testing market, 2013 - 2024 (USD Billion)
                          6.6.2 South Africa
                                6.6.2.1 South Africa Clinical laboratory testing market, 2013 - 2024 (USD Billion)

Chapter 7 Competitive Landscape
                     7.1 Strategy Framework
                     7.2 Market Participation Categorization
                     7.3 Company Profiles
                          7.3.1 Abbott Laboratories
                                7.3.1.1 Company overview
                                7.3.1.2 Financial performance
                                7.3.1.3 Product benchmarking
                                7.3.1.4 Strategic initiatives
                          7.3.2 ARUP Laboratories (Associated Regional & University Pathologists Inc.)
                                7.3.2.1 Company overview
                                7.3.2.2 Financial performance
                                7.3.2.3 Product benchmarking
                                7.3.2.4 Strategic initiatives
                          7.3.3 OPKO Health, Inc. (Bio-Reference Labs)
                                7.3.3.1 Company overview
                                7.3.3.2 Financial performance
                                7.3.3.3 Product benchmarking
                                7.3.3.4 Strategic initiatives
                          7.3.4 Bioscientia Institut fur Medizinische Diagnostik GmbH
                                7.3.4.1 Company overview
                                7.3.4.2 Financial performance
                                7.3.4.3 Product benchmarking
                                7.3.4.4 Strategic initiatives
                          7.3.5 Charles River Laboratories International, Inc.
                                7.3.5.1 Company overview
                                7.3.5.2 Financial performance
                                7.3.5.3 Product benchmarking
                                7.3.5.4 Strategic initiatives
                          7.3.6 Neogenomics Laboratories, Inc. (Clarient, Inc.)
                                7.3.6.1 Company overview
                                7.3.6.2 Financial performance
                                7.3.6.3 Product benchmarking
                                7.3.6.4 Strategic initiatives
                          7.3.7 Genoptix
                                7.3.7.1 Company overview
                                7.3.7.2 Financial performance
                                7.3.7.3 Product benchmarking
                          7.3.8 Healthscope
                                7.3.8.1 Company overview
                                7.3.8.2 Financial performance
                                7.3.8.3 Product benchmarking
                          7.3.9 Labco S.A
                                7.3.9.1 Company overview
                                7.3.9.2 Financial performance
                                7.3.9.3 Product benchmarking
                                7.3.9.4 Strategic initiatives
                          7.3.10 Laboratory Corporation of America Holdings (LabCorp)
                                7.3.10.1 Company overview
                                7.3.10.2 Financial performance
                                7.3.10.3 Product benchmarking
                                7.3.10.4 Strategic initiatives
                          7.3.11 Qiagen N.V
                                7.3.11.1 Company overview
                                7.3.11.2 Financial performance
                                7.3.11.3 Product benchmarking
                                7.3.11.4 Strategic initiatives
                          7.3.12 Quest Diagnostics
                                7.3.12.1 Company overview
                                7.3.12.2 Financial performance
                                7.3.12.3 Product benchmarking
                                7.3.12.4 Strategic initiatives
                          7.3.13 Siemens Healthineers
                                7.3.13.1 Company overview
                                7.3.13.2 Financial Performance
                                7.3.13.3 Product benchmarking
                                7.3.13.4 Strategic initiatives
                          7.3.14 Sonic Healthcare Ltd.
                                7.3.14.1 Company overview
                                7.3.14.2 Financial performance
                                7.3.14.3 Product benchmarking
                                7.3.14.4 Strategic initiatives
                          7.3.15 Spectra Laboratories (Fresenius Medical Care Holdings, Inc.)
                                7.3.15.1 Company overview
                                7.3.15.2 Financial Performance
                                7.3.15.3 Product benchmarking
                                7.3.15.4 Strategic initiatives
                          7.3.16 Merck KgaA (Merck Millipore Sigma)
                                7.3.16.1 Company overview
                                7.3.16.2 Financial performance
                                7.3.16.3 Product benchmarking
                                7.3.16.4 Strategic initiatives
                          7.3.17 Tulip Group
                                7.3.17.1 Company overview
                                7.3.17.2 Financial performance
                                7.3.17.3 Product benchmarking
                          7.3.18 Biosino Bio-technology and Science Inc
                                7.3.18.1 Company overview
                                7.3.18.2 Financial performance
                                7.3.18.3 Product benchmarking
                                7.3.18.4 Strategic initiatives

List of Tables


TABLE 1 Country share estimation
TABLE 2 North America clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 3 North America liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 4 North America clinical laboratory testing market estimates and forecasts, by end, 2013 - 2024 (USD Billion)
TABLE 5 U.S. clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 6 U.S. liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 7 U.S. clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 8 Canada Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 9 Canada liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 10 Canada clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 11 Europe Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 12 Europe liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 13 Europe clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 14 UK Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 15 UK liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 16 UK clinical laboratory testing market estimates and forecasts, by end, 2013 - 2024 (USD Billion)
TABLE 17 Germany Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 18 Germany liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 19 Germany clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 20 Asia Pacific Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 21 Asia Pacific liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 22 Asia Pacific clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 23 Japan Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 24 Japan liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 25 Japan clinical laboratory testing market estimates and forecasts, by end, 2013 - 2024 (USD Billion)
TABLE 26 China Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 27 China liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 28 China clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 29 India Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 30 India liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 31 India clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 32 Latin America Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 33 Latin America liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 34 Latin America clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 35 Brazil Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 36 Brazil liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 37 Brazil clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 38 Mexico Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 39 Mexico liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 40 Mexico clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 41 MEA Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 42 MEA liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 43 MEA clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)
TABLE 44 South Africa Clinical laboratory testing market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 45 South Africa liver panel market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
TABLE 46 South Africa clinical laboratory testing market estimates and forecasts, by end-use, 2013 - 2024 (USD Billion)